Please login first

Webinar on Clinical Medicine | New Horizons in Treating Liver Diseases in the COVID Era

22 Jul 2022, 16:00 (CEST)

Coronavirus Disease, Liver Surgery, Liver Transplantation, Organ Procurement
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us

Welcome from the Chair

9th Webinar on Clinical Medicine

New Horizons in Treating Liver Diseases in the COVID Era

The Coronavirus-19 related diseases (COVID-19), since March 2020, has spread worldwide, and has rapidly become a public health matter with several unmet issues. The global impact of COVID-19 is still perceptible both on the economic side and on that of health systems. The sudden and unexpected COVID-19 pandemic has forced all health systems to rethink the allocation of their health resources. In the acute phase of the pandemic, a large part of the resources was devoted to treating COVID-19 patients, reducing the possibility of treating many other acute and chronic diseases. Thus, during these two years, some sectors of medicine have inevitably suffered particularly from the scarcity of resources destined for them. The purpose of this webinar is to highlight how the COVID-19 pandemic has influenced the surgical treatment of some liver diseases and how it has impacted in liver transplanted patients and in the organ procurement systems for liver transplantation.

Date: 22 July 2022

Time: 4:00 pm CEST | 9:00 am CDT | 10:00 am EDT | 10:00 pm CST Asia

Webinar ID: 859 7168 2424

Webinar Secretariat:


Hepatology and Liver Transplantation Unit, Academic Hospital, University of Udine, Italy

Physician and clinical researcher, focused to the management of patients with severe liver diseases, and of liver transplanted patients. Degree in Internal Medicine in 1994 at the University of Padova (Italy). From 1995 to 1996 visiting professor of medicine at the International Center of Genetic Engineering and Biotechnology (ICGEB) in Area Science Park (Trieste, Italy). From 2010 to 2016 president of the liver transplant commission of the Italian association for the study of the liver. In 2011, honorary degree of transplant hepatologist from the European board of transplant medicine and in 2012 from the Italian association for the study of the liver. In 2012, acquisition of national eligibility for the role of full professor of internal medicine and full professor of gastroenterology. Since 2018 director of the Hepatology and liver transplantation unit at the academic hospital-University of Udine (Italy). Author of more than 200 English language peer review papers cited in PubMed and of one book chapter in liver transplantation. Reviewer of plenty authoritative international Journals, mainly in the field of Hepatology and Gastroenterology.

Invited Speakers

Surgery, Texas Tech University Health Sciences Center, El Paso, TX, USA

Dr Konstantinidis was born and raised in Greece and graduated from the Aristotle University of Thessaloniki Medical School. He completed research fellowships at Massachusetts General Hospital and Memorial Sloan-Kettering Cancer Center on hepatobiliary and pancreatic cancer with several seminal publications. He completed his complex general surgical oncology fellowship at City of Hope National Cancer Center and he is currently an assistant professor at Texas Tech University. His clinical and research focus are pancreas and hepatobiliary cancer, stomach cancer, HIPEC, robotic surgery and patient frailty.

Department of Surgery, City of Hope Medical Center, Duarte, CA, USA

Dr. Yuman Fong is the Sangiacomo Chair and Chairman of the Department of Surgery at the City of Hope Medical Center. Dr. Fong is best known for his extensive work in the field of liver and pancreatic surgery. He helped usher in robotic techniques for HPB surgery. He is editor of the SAGES Atlas of Robotic Surgery. For his clinical work, he was awarded the Layton F. Rikkers Master Clinician Award from the SSAT. He has assisted in the design and deployment of many novel surgical tools. For his contributions to surgical research, he has been awarded the Flance-Karl Award from American Surgical Association. His work in medical engineering has led to his election to the American Institute of Medical and Biologic Engineering. His laboratory focus is in design of gene and immune cell therapies for cancer. His leadership on the national level has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health. He is Founding Editor-in-Chief of Molecular Therapy Oncolytics (Cell Press, official journal of the ASGCT). He has co-authored over 1000 papers (h-index=141) and 22 textbooks. He has also been elected to the American Society of Clinical Investigation and to the National Academy of Medicine.

Department of Clinical Medicine and Surgery, Gastroenterology and Hepatology Unit, University of Naples “Federico II”, Naples, Italy

Dr Maria Guarino, MD, PhD., is a Gastroenterologist with special interests in liver diseases. She is teaching assistant at the School of Medicine, University of Naples “Federico II”. Since December 2018 she has been an Attending Physician, at the Gastroenterology and Hepatology Unit of the University Hospital “Federico II” of Naples. During 2017 and 2018 she attended a Basic Research fellowship at the Hepatology Unit, Department of Clinical Research, Inselspital, University of Bern, Switzerland – mentor Prof. Jean-François Dufour.

Multivisceral Transplant Unit-Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University Hospital of Padua, Padova, Italy

Professor Burra is Full Professor of Gastroenterology and Head of the Multivisceral Transplantation Unit at Padua University, Italy. Between 2015 and 2021 she was ViceRector on Research Training at Padua University, Italy. From 2021 she is Rector’s Delegate for Specialisation Schools and the Centre for Post Graduate Specialised Training at Padua University, Italy. Patrizia Burra is clinically and scientifically interested in studies in the field of liver transplantation, mainly with regard to HBV prophylaxis after transplantation, liver transplantation for NAFLD and NASH including evaluation of frailty and obesity, early liver transplantation for acute alcoholic hepatitis. In addition, she is involved in the clinical management of patients with hepatocellular carcinoma, primary sclerosing cholangitis, and cholangiocarcinoma. Currently she is Chair of the Public Affairs Committee 2022–2025 at United European Gastroenterology (UEG) and General Secretary of the Italian Society of Gastroenterology (SIGE). In 2021 she received the EASL recognition award 2021 and she obtained the Fellow of the American Association for the Study of Liver Diseases (FAASLD). She is also President of the NGO Marina Minnaja Foundation for the research and study of liver transplantation. Currently she is Co-chair of The Lancet – EASL Commission on liver diseases in Europe from 2018 and Deputy Editor of Journal of Hepatology from 2019. She has authored over 370 articles in international peer-reviewed journals, with an H-index of 58.


This is a FREE webinar. The number of participants to the live session is limited but the recording will be made available on Sciforum shortly afterwards. Registrations with academic institutional email addresses will be prioritized.

Certificates of attendance will be delivered to those who attend the live webinar.

Webinar Content

To view this content, you need to be registered and logged in to Sciforum platform.



Time in CDT

Time in CEST

Prof. Dr. Pierluigi Toniutto

Chair Introduction

9:00 - 9:10 am

4:00 - 4:10 pm

Dr. Ioannis Konstantinidis

Advances in the Treatment of Metastatic Liver Malignancies

9:10 - 9:30 pm

4:10 - 4:30 pm

Dr. Yuman Fong

Minimally Invasive Liver Surgery

9:30 - 9:50 pm

4:30 - 4:50 pm

Dr. Maria Guarino

Incidence and Clinical Impact of COVID-19 in Liver Transplant Recipients

9:50 - 10:10 pm

4:50 - 5:10 pm

Prof. Dr. Patrizia Burra

The Impact of COVID-19 in the Liver Transplant Programs and in Organ Procurement Systems

10:10 - 10:30 pm

5:10 - 5:30 pm

Q&A Session

10:30 - 10:55 pm

5:30 - 5:55 pm

Closing of Webinar
Prof. Dr. Pierluigi Toniutto

10:55 - 11:00 pm

5:55 - 6:00 pm

Relevant SI

New Therapies of Liver Diseases
Guest Editor: Dr. Pierluigi Toniutto
Deadline for manuscript submissions: closed (31 July 2021)

Multimodal Treatment in Metastatic Liver Cancer
Guest Editors: Prof. Dr. Aristotelis Perrakis, Dr. Nikolaos Vassos & Dr. Ioannis Konstantinidis
Deadline for manuscript submissions: closed (25 June 2022)

Clinical Impact of COVID-19 on Liver Diseases
Guest Editor: Dr. Maria Guarino
Deadline for manuscript submissions: 25 January 2023

Sponsors and Partners